BMP6, a potential biomarker of inflammatory fibrosis and promising protective factor for dilated cardiomyopathy
Abstract Background Dilated cardiomyopathy (DCM) stands as one of the most prevalent and severe causes of heart failure. Inflammation plays a pivotal role throughout the progression of DCM to heart failure, while age acts as a natural predisposing factor for all cardiovascular diseases. These two fa...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2025-01-01
|
| Series: | Chinese Medicine |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s13020-025-01062-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832594436680318976 |
|---|---|
| author | Feng Jiang Jiayang Tang Xiaoqi Wei Hai Pan Xinyi Fan Peng Zhang Shuzhen Guo |
| author_facet | Feng Jiang Jiayang Tang Xiaoqi Wei Hai Pan Xinyi Fan Peng Zhang Shuzhen Guo |
| author_sort | Feng Jiang |
| collection | DOAJ |
| description | Abstract Background Dilated cardiomyopathy (DCM) stands as one of the most prevalent and severe causes of heart failure. Inflammation plays a pivotal role throughout the progression of DCM to heart failure, while age acts as a natural predisposing factor for all cardiovascular diseases. These two factors often interact, contributing to cardiac fibrosis, which is both a common manifestation and a pathogenic driver of adverse remodeling in DCM-induced heart failure. Method Bulk RNA-seq, single-cell RNA-seq, Mendelian randomization analysis, animal model construction, and BMP6 knockdown were utilized to identify and validate potential specific markers and targets for intervention in DCM heart failure. Results We found that DCM hearts exhibit pronounced inflammatory cell infiltration and fibrosis. Both bulk RNA-seq and single-cell RNA-seq analyses revealed aberrant BMP6 expression specifically in fibroblasts. The ROC curve underscores the high specificity of BMP6 in relation to DCM, while Mendelian randomization analysis further confirms BMP6 as a protective factor against DCM. Notably, BMP6 knockdown led to a decrease in SMAD6 expression and a marked elevation in COL1A1 expression levels, indicating its antifibrotic role. Conclusion BMP6 emerges as a promising biomarker for DCM, and its functional role in exerting an antifibrotic effect underscores its potential as a therapeutic target. |
| format | Article |
| id | doaj-art-bf85d495d15b4752998d4216747f4d96 |
| institution | Kabale University |
| issn | 1749-8546 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | BMC |
| record_format | Article |
| series | Chinese Medicine |
| spelling | doaj-art-bf85d495d15b4752998d4216747f4d962025-01-19T12:38:44ZengBMCChinese Medicine1749-85462025-01-0120111410.1186/s13020-025-01062-9BMP6, a potential biomarker of inflammatory fibrosis and promising protective factor for dilated cardiomyopathyFeng Jiang0Jiayang Tang1Xiaoqi Wei2Hai Pan3Xinyi Fan4Peng Zhang5Shuzhen Guo6School of Traditional Chinese Medicine, Beijing University of Chinese MedicineSchool of Traditional Chinese Medicine, Beijing University of Chinese MedicineSchool of Traditional Chinese Medicine, Beijing University of Chinese MedicineSchool of Traditional Chinese Medicine, Beijing University of Chinese MedicineSchool of Traditional Chinese Medicine, Beijing University of Chinese MedicineWuhan Hospital of Traditional Chinese MedicineSchool of Traditional Chinese Medicine, Beijing University of Chinese MedicineAbstract Background Dilated cardiomyopathy (DCM) stands as one of the most prevalent and severe causes of heart failure. Inflammation plays a pivotal role throughout the progression of DCM to heart failure, while age acts as a natural predisposing factor for all cardiovascular diseases. These two factors often interact, contributing to cardiac fibrosis, which is both a common manifestation and a pathogenic driver of adverse remodeling in DCM-induced heart failure. Method Bulk RNA-seq, single-cell RNA-seq, Mendelian randomization analysis, animal model construction, and BMP6 knockdown were utilized to identify and validate potential specific markers and targets for intervention in DCM heart failure. Results We found that DCM hearts exhibit pronounced inflammatory cell infiltration and fibrosis. Both bulk RNA-seq and single-cell RNA-seq analyses revealed aberrant BMP6 expression specifically in fibroblasts. The ROC curve underscores the high specificity of BMP6 in relation to DCM, while Mendelian randomization analysis further confirms BMP6 as a protective factor against DCM. Notably, BMP6 knockdown led to a decrease in SMAD6 expression and a marked elevation in COL1A1 expression levels, indicating its antifibrotic role. Conclusion BMP6 emerges as a promising biomarker for DCM, and its functional role in exerting an antifibrotic effect underscores its potential as a therapeutic target.https://doi.org/10.1186/s13020-025-01062-9BMP6Dilated cardiomyopathyCardiac fibrosisHeart failure |
| spellingShingle | Feng Jiang Jiayang Tang Xiaoqi Wei Hai Pan Xinyi Fan Peng Zhang Shuzhen Guo BMP6, a potential biomarker of inflammatory fibrosis and promising protective factor for dilated cardiomyopathy Chinese Medicine BMP6 Dilated cardiomyopathy Cardiac fibrosis Heart failure |
| title | BMP6, a potential biomarker of inflammatory fibrosis and promising protective factor for dilated cardiomyopathy |
| title_full | BMP6, a potential biomarker of inflammatory fibrosis and promising protective factor for dilated cardiomyopathy |
| title_fullStr | BMP6, a potential biomarker of inflammatory fibrosis and promising protective factor for dilated cardiomyopathy |
| title_full_unstemmed | BMP6, a potential biomarker of inflammatory fibrosis and promising protective factor for dilated cardiomyopathy |
| title_short | BMP6, a potential biomarker of inflammatory fibrosis and promising protective factor for dilated cardiomyopathy |
| title_sort | bmp6 a potential biomarker of inflammatory fibrosis and promising protective factor for dilated cardiomyopathy |
| topic | BMP6 Dilated cardiomyopathy Cardiac fibrosis Heart failure |
| url | https://doi.org/10.1186/s13020-025-01062-9 |
| work_keys_str_mv | AT fengjiang bmp6apotentialbiomarkerofinflammatoryfibrosisandpromisingprotectivefactorfordilatedcardiomyopathy AT jiayangtang bmp6apotentialbiomarkerofinflammatoryfibrosisandpromisingprotectivefactorfordilatedcardiomyopathy AT xiaoqiwei bmp6apotentialbiomarkerofinflammatoryfibrosisandpromisingprotectivefactorfordilatedcardiomyopathy AT haipan bmp6apotentialbiomarkerofinflammatoryfibrosisandpromisingprotectivefactorfordilatedcardiomyopathy AT xinyifan bmp6apotentialbiomarkerofinflammatoryfibrosisandpromisingprotectivefactorfordilatedcardiomyopathy AT pengzhang bmp6apotentialbiomarkerofinflammatoryfibrosisandpromisingprotectivefactorfordilatedcardiomyopathy AT shuzhenguo bmp6apotentialbiomarkerofinflammatoryfibrosisandpromisingprotectivefactorfordilatedcardiomyopathy |